Litcius/Paper detail

Overriding sorafenib resistance via blocking lipid metabolism and Ras by sphingomyelin synthase 1 inhibition in hepatocellular carcinoma

Haofeng Lu, Lin Zhou, Hongping Zuo, Wenjin Le, Jianfei Hu, Tiequan Zhang, Mi Li, Yufeng Yuan

2020Cancer Chemotherapy and Pharmacology23 citationsDOI

Topics & Concepts

SorafenibSphingolipidHepatocellular carcinomaCeramideCancer researchSphingomyelinCarcinogenesisChemistryPharmacologyBiologyApoptosisBiochemistryCholesterolGeneSphingolipid Metabolism and SignalingCancer, Lipids, and MetabolismMetabolomics and Mass Spectrometry Studies
Overriding sorafenib resistance via blocking lipid metabolism and Ras by sphingomyelin synthase 1 inhibition in hepatocellular carcinoma | Litcius